Novel glycolipid agents for killing cisplatin-resistant human epithelial ovarian cancer cells

BACKGROUND: Chemotherapy resistance is one of the major factors contributing to mortality from human epithelial ovarian cancer (EOC). Identifying drugs that can effectively kill chemotherapy-resistant EOC cells would be a major advance in reducing mortality. Glycosylated antitumour ether lipids (GAE...

Descripción completa

Detalles Bibliográficos
Autores principales: Moraya, Amani I., Ali, Jennifer L., Samadder, Pranati, Liang, Lisa, Morrison, Ludivine Coudière, Werbowetski-Ogilvie, Tamra E., Ogunsina, Makanjuola, Schweizer, Frank, Arthur, Gilbert, Nachtigal, Mark W.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5429581/
https://www.ncbi.nlm.nih.gov/pubmed/28499442
http://dx.doi.org/10.1186/s13046-017-0538-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5429581/
https://www.ncbi.nlm.nih.gov/pubmed/28499442
http://dx.doi.org/10.1186/s13046-017-0538-9

Ejemplares similares